Skip to content

The raw feed

Latest filings

Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.

DateCompanyInsiderTransactionSharesPriceValueHoldings afterFiled
Jun 23, 2026SYRE
Aeglea BioTherapeutics, Inc.
Fairmount Funds Management LLC
director
CConversion
Common Stockindirect: By Fairmount Healthcare Fund II L.P.
+666,680--4,684,781Jun 23, 2026
Jun 23, 2026SYRE
Aeglea BioTherapeutics, Inc.
Fairmount Funds Management LLC
director
CConversion
Series B Preferred Stockderivativeindirect: Fairmount Healthcare Fund II LP
-16,667$0.00$00Jun 23, 2026
Jun 18, 2026PUBM
PubMatic, Inc.
Rajeev K. Goel
CHIEF EXECUTIVE OFFICER
CConversion
Class A Common Stock10b5-1
+21,871--43,077Jun 22, 2026
Jun 18, 2026PUBM
PubMatic, Inc.
Rajeev K. Goel
CHIEF EXECUTIVE OFFICER
CConversion
Class B Common Stockderivative10b5-1
-21,871$0.00$0210,984Jun 22, 2026
Jun 17, 2026NSA
National Storage Affiliates Trust
William S. Cowan Jr.
Chief Strategy Officer
CConversion
LTIP Unitsderivative
-10,471--140,923Jun 22, 2026
Jun 17, 2026NSA
National Storage Affiliates Trust
William S. Cowan Jr.
Chief Strategy Officer
CConversion
Class A OP Unitsderivative
+10,471--197,016Jun 22, 2026
Jun 18, 2026NTRP
SIGMA ADDITIVE SOLUTIONS, INC.
David T Jiang
director
CConversion
Warrants for Common Stockderivative
+18,200$0.00$092,289Jun 22, 2026
Jun 17, 2026SER
AgeX Therapeutics, Inc.
Jay Venkatesan
director
CConversion
Common Stockindirect: The Jay Venkatesan Legacy Trust
+224,152$2.25$504k231,705Jun 22, 2026
Jun 17, 2026SER
AgeX Therapeutics, Inc.
Jay Venkatesan
director
CConversion
Series A Convertible Preferred Stockderivativeindirect: The Jay Venkatesan Legacy Trust
-96,525$2.25$217k0Jun 22, 2026
Jun 17, 2026SER
AgeX Therapeutics, Inc.
Gregory Bailey
director
CConversion
Common Stock
+1,770,805$2.25$4.0M1,897,445Jun 22, 2026
Jun 17, 2026SER
AgeX Therapeutics, Inc.
Gregory Bailey
director
CConversion
Common Stock
+6,666,667$2.25$15M8,564,382Jun 22, 2026
Jun 17, 2026SER
AgeX Therapeutics, Inc.
Gregory Bailey
director
CConversion
Series A Convertible Preferred Stockderivative
-762,548$2.25$1.7M0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Common Stockindirect: HRTG CIF 2024, L.P.
+2,050,166--2,050,166Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Common Stockindirect: HRTG PV, L.P.
+6,150,502--6,150,502Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Common Stockindirect: HRTG PV, L.P.
+3,242,993--9,393,495Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Common Stockindirect: HRTG PV, L.P.
+2,348,373--11,741,868Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Series A Redeemable Convertible Preferred Stockderivativeindirect: HRTG CIF 2024, L.P.
-1,287,146--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Series A Redeemable Convertible Preferred Stockderivativeindirect: HRTG PV, L.P.
-3,861,440--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Series B Redeemable Convertible Preferred Stockderivativeindirect: HRTG PV, L.P.
-2,036,033--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Hrtg Gpe, LLC
owner
CConversion
Series B-1 Redeemable Convertible Preferred Stockderivativeindirect: HRTG PV, L.P.
-1,474,368--0Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
WaterBridge Resources LLC
owner
CConversion
Class A sharesindirect: See Footnotes
+4,464,012$0.00$07,875,747Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
WaterBridge Resources LLC
owner
CConversion
WBI Operating LLC Unitsderivativeindirect: See Footnotes
-4,464,012$0.00$051,762,663Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
WBR Holdings LLC
owner
CConversion
Class A sharesindirect: See Footnotes
+4,464,012$0.00$07,875,747Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
WBR Holdings LLC
owner
CConversion
WBI Operating LLC Unitsderivativeindirect: See Footnotes
-4,464,012$0.00$051,762,663Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
ARCH Venture Partners XIII, LLC
director, owner
CConversion
Common Stockindirect: By: ARCH Venture Fund XIII, L.P.
+13,792,035--13,792,035Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
ARCH Venture Partners XIII, LLC
director, owner
CConversion
Series A Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-5,148,587--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
ARCH Venture Partners XIII, LLC
director, owner
CConversion
Series B Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-1,204,000--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
ARCH Venture Partners XIII, LLC
director, owner
CConversion
Series B-1 Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-2,306,401--0Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
David N Capobianco
director, owner
CConversion
Class A sharesindirect: See Footnotes
+4,464,012$0.00$07,875,747Jun 22, 2026
Jun 22, 2026WBI
WaterBridge Infrastructure LLC
David N Capobianco
director, owner
CConversion
WBI Operating LLC Unitsderivativeindirect: See Footnotes
-4,464,012$0.00$051,762,663Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Paul L Berns
director, owner
CConversion
Common Stockindirect: By ARCH Venture Fund XIII, L.P.
+13,792,035--13,792,035Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Paul L Berns
director, owner
CConversion
Series A Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-5,148,587--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Paul L Berns
director, owner
CConversion
Series B Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-1,204,000--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Paul L Berns
director, owner
CConversion
Series B-1 Preferred Stockderivativeindirect: By ARCH Venture Fund XIII, L.P.
-2,306,401--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Common Stockindirect: By AEG 2021 Trust
+28,702--5,665,090Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Common Stockindirect: By KCM 2023 Trust
+41,001--2,422,520Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Common Stockindirect: By spouse
+498,692--498,692Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Series A Preferred Stockderivativeindirect: By AEG 2021 Trust
-18,020--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Series A Preferred Stockderivativeindirect: By KCM 2023 Trust
-25,742--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Anastasios Gianakakos
President & CEO
CConversion
Series B Preferred Stockderivativeindirect: By spouse
-313,092--0Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Jay Edelberg
Chief Medical Officer
CConversion
Common Stock
+97,587--135,543Jun 22, 2026
Jun 17, 2026KARD
Kardigan, Inc.
Jay Edelberg
Chief Medical Officer
CConversion
Series B Preferred Stockderivative
-61,268--0Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
James A Graf
CEO and CFO
CConversion
Class A Ordinary Shares
+5,659,999--5,659,999Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
James A Graf
CEO and CFO
CConversion
Class B Ordinary Sharesderivative
-5,659,999$0.00$01Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Kenneth Weinstein
director
CConversion
Class A Ordinary Shares
+30,000--30,000Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Kenneth Weinstein
director
CConversion
Class B Ordinary Sharesderivative
-30,000$0.00$00Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Fred S Zeidman
director
CConversion
Class A Ordinary Shares
+30,000--30,000Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Fred S Zeidman
director
CConversion
Class B Ordinary Sharesderivative
-30,000$0.00$00Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Louis Belanger-Martin
director
CConversion
Class A Ordinary Shares
+30,000--30,000Jun 22, 2026
Jun 18, 2026TONT
Graf Global Corp.
Louis Belanger-Martin
director
CConversion
Class B Ordinary Sharesderivative
-30,000$0.00$00Jun 22, 2026

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.